首页> 外文期刊>Journal of child and adolescent psychopharmacology >Effect of OROS Methylphenidate on Encopresis in Children with Attention-Deficit/Hyperactivity Disorder
【24h】

Effect of OROS Methylphenidate on Encopresis in Children with Attention-Deficit/Hyperactivity Disorder

机译:OROS哌醋甲酯对注意缺陷/多动障碍儿童的日遗症的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: Although encopresis shows a high rate of comorbidity in patients with attention-deficit/hyperactivity disorder (ADHD), the etiologic origin of this relationship and the effect of ADHD drugs on encopresis are unclear. In this chart review, we explored the effect of OROS long-acting methylphenidate (MPH) treatment on encopresis in children with ADHD. We also evaluated the relationship between the clinical variables of ADHD and encopresis.
机译:目的:尽管注意缺陷多动障碍(ADHD)患者的粪便合并症显示出较高的合并症,但这种关系的病因起源以及ADHD药物对粪便的影响尚不清楚。在本图表审查中,我们探讨了OROS长效哌醋甲酯(MPH)治疗对多动症儿童共遗症的影响。我们还评估了多动症的临床变量和encopresis之间的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号